Stem Cell-Based Clinical Trials for Diabetes Mellitus
Since its introduction more than twenty years ago, intraportal allogeneic cadaveric islet transplantation has been shown to be a promising therapy for patients with Type I Diabetes (T1D). Despite its positive outcome, the impact of islet transplantation has been limited due to a number of confoundin...
Saved in:
Published in | Frontiers in endocrinology (Lausanne) Vol. 12; p. 631463 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
26.02.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!